Recursion Pharmaceuticals Inc - Class A
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Recursion Pharmaceuticals Inc - Class A
Current Price
$2.93
-3.62%GoodMoat Value
$0.63
78.5% overvaluedProfile
Valuation (TTM)
Market Cap$1.55B
P/E-2.76
EV—
P/B1.37
Shares Out527.40M
P/Sales23.27
Revenue$66.41M
EV/EBITDA—
Recursion Pharmaceuticals Inc - Class A (RXRX) Stock News
RXRX Stock News & Headlines
Latest stock news and headlines for Recursion Pharmaceuticals Inc - Class A (RXRX). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $2.93. Market cap: $1.55B. Sector: Healthcare. Industry: Biotechnology. This page aggregates the latest news articles relevant to RXRX from financial news sources, helping investors stay current on events that may impact Recursion Pharmaceuticals Inc - Class A's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Recursion Pharmaceuticals Inc - Class A (RXRX).